Purpose The onset of drug-resistance is a significant reason behind treatment failure in multiple myeloma (MM). well much like modulation of medication influx-efflux transporters SLC7A5/LAT1 as well as the ATP-binding cassette (ABC) transporter ABCC1/MRP1. Finally, treatment of SCID/NOD mice bearing human being melphalan-refractory MM xenografts with systemic LNA-i-miR-221 melphalan overcame drug-resistance, evidenced by development inhibition… Continue reading Purpose The onset of drug-resistance is a significant reason behind treatment